The incidence of anaphylaxis following vaccination with Pfizer–BioNTech’s COVID-19 vaccine is slightly higher than that of schedule vaccines, so health professionals must be able to recognise this potentially fatal condition and differentiate it from immunisation stress-related responses, explain Marleen Hart, Aimee Brass and Shelley Kininmonth
For the last decade, Martin Woodbridge has worked with regulators, and industry and health professionals to promote the rational use of cannabis-based medicines. Here, he considers the introduction of cannabis-based medicines to New Zealand and explores what it means for pharmacy practice
Christchurch pharmacist Sarah Mooney discusses the variety of women’s gynaecological issues before focusing in on pelvic pain and the many different causes of vaginal itching
Home visits to connect with whānau are one of the most rewarding parts of her new role as a primary care pharmacist, writes Dianna Gibbs, from Ngā Kaitiaki o te Puna Rongoā
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes